Participation notification by BlackRock Inc. Brussels, Belgium - November 27, 2024 - 8:30 CESTAccording to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (12 Throgmorton Avenue ...
FRONTLINE PLC REPORTS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2024 Frontline plc (the "Company", "Frontline," "we," "us," or "our"), today reported unaudited results for the three and nine ...
Hydro Reserve, a leading innovator in wastewater management, is transforming the industry with its groundbreaking mechanical filtration technology, a unique, chemical-free solution delivering unparall ...
FDA Marketing Authorization Decision on Early Stage-Low Risk Breast Cancer Expected in Q1 2025 Conference call to be held today at 10:00 am Eastern Time CAESAREA ...
Fiscal 2024 Revenue on track to exceed Fiscal 2023 RevenueFull Year Revenue and Gross Margin ahead of 2023 as of OctoberQ4 2024 performance expected to outpace Q4 2023Plurilock will host a webinar and ...
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced SS&C Blue Prism has been named a process orchestration Leader in the Everest Group ...
Insurance business units report positive operating performance while facing mounting industry-wide cost pressures Allegheny Health Network reports 9% total revenue ...
NORTHAMPTON, MA / ACCESSWIRE / November 26, 2024 / KeyBankIUL plans to enhance the ECP by offering more comprehensive programming and services tailored to each entrepreneur's business stage at the tim ...
Roche's strategic landscape is experiencing significant shifts as the Swiss pharmaceutical giant announces a $1.5 billion acquisition of Poseida Therapeutics. The deal, scheduled to conclude in Q1 202 ...
VinFast Auto Ltd. ("VinFast" or the "Company") (Nasdaq: VFS), a pure-play electric vehicle ("EV") manufacturer with the mission of making EVs accessible ...
Manchester United (NYSE: MANU; the "Company" and the "Group") today announced financial results for the 2025 fiscal first quarter ended 30 September 2024. Management ...
Landmark Overdose Protection Clinical Trial of PF614-MPAR ~~ Expects Early Interim Data in 1Q 2025 ~ SAN DIEGO, CA / ACCESSWIRE / November 26, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" ...